ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2025
Following the Hyperkalemia Trail: A Case Report of ECG Changes and Treatment Responses.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hyperkalemia is an electrolyte disturbance with potentially severe consequences, including dysrhythmia and even asystole and death. Hyperkalemia can result from multiple factors, including impaired renal function, adverse drug reactions, adrenal disease, and heritable mutations. Although electrocardiogram (ECG) manifestations are well described, presentations can vary, and treatment response can be unpredictable. This case highlights dynamic ECG changes associated with severe hyperkalemia and the challenges associated with its management. Case Presentation: An 81-year-old man with chronic kidney disease presented with muscle weakness and bradycardia. An ECG showed significant changes, including prolonged QRS duration and peaked T waves, corresponding to a serum potassium level of 9.8 mEq/L. The patient received calcium gluconate, albuterol, insulin, patiromer, and hemodialysis. However, fluctuating potassium levels required ongoing interventions. Conclusions: This case underscores the importance of serial monitoring and dynamic treatment strategies in managing hyperkalemia, highlighting the critical role of ECG in guiding care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.